Figure 3 — SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients

Research Paper|Volume 12, Issue 19|pp. 19316–19324

SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients

Back to articleFigure 3(4 of 5)

100%

Figure 3.Tumor-infiltrating immune cells associated with SYNE1 mutation in ccRCC. (D) Heatmap of 22 immune cell types based on SYNE1 mutation. The blue color represents the mt group, and red represents the wt group.